Mentor Capital, Inc invests in and acquires cannabis companies both in the medical and social sectors. This publicly traded private equity firm operates by providing smaller companies with passive equity and investing in shelf IPOs. Its aim is to provide founders and small-business owners with public market access.
The company is authorized to bring up USD 23 M from the public market. If a cannabis company wants to obtain public market funding, it may approach Mentor Capital and trade in 10% to 60% of its own business. In turn, Mentor Capital works on delivering higher prices for smaller slices of business, owing to its capital structure and investing approach.
Mentor Capital’s cannabis portfolio includes companies in varied sectors. Namely, these are: Brighter Day Health, GW Pharmaceuticals (having the largest index holding), MicroCannaBiz LLC, Nevada Cannabis Ventures, Shaw Capital Management, Bhang Medicinal Chocolate (agreement currently in dispute), Bhang Financial, and Waste Consolidators, Inc.
The company reaches both the medical and the recreational cannabis sectors, but it has stated that its preferred focus is on the medicine. Among its investments is in the science of cancer immunotheraphy. However, it intends to fully transition to the marijuana industry in time.
Mentor Capital’s long history began in 1985, when it was founded as Main Street Athletic Clubs, a gym company in California. In 2008, it reinvented itself to become Mentor Capital, Inc, with investments in the cancer sector. According to the company, it shifted to the marijuana space when the cancer sector experienced a collapse.
Today, Mentor Capital, Inc is traded as MNTR in the OTC markets. Its market cap is at USD 5.51 M.
Top executives at Mentor Capital include Founder, CEO, and President Chester Billingsley, CFO Lori J. Stansfield, and Director James J. Blazeck.
Mentor Capital, Inc.
P.O. Box 1709
Ramona, CA 92065
Yahoo! Finance: MNTR News
Latest Financial News for MNTR